It was a medical enigma: Why do many black patients respond differently to a class of heart drugs called beta blockers? Researchers now say a genetic variant allows 40 percent of black patients to produce their own version of the drugs. Dr. Stephen Liggett tells The Takeaway about his study and the potential impacts on health care.
Guest: Dr. Stephen Liggett, director of Cardiopulmonary Genomics at University of Maryland Medical Center.
- The price of food has a human cost
- The latest restaurant trend: Eat now, pay whatever
- Financial illiteracy in America and economic crises
- The songs that torture us
- Investigative report: Hastiness in natural gas drilling jeopardizes local water
- Video: Classic food jingles
- The Takeaway for July 22, 2008
- Mornings need a make over. What would you change?
- "The Measure of America" finds disparities in our standards of living
- At 2008 Olympics, diversity goes to the mat
The show is a co-production of WNYC Radio and Public Radio International,
in collaboration with The BBC World Service, New York Times Radio and WGBH Boston.
